Boston Trust Walden’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
Other funds holding MD
BHG
CS
EM
Boston Trust Walden's MD Position: Q2 2018 in Review
Boston Trust Walden sold out of Pediatrix Medical (MD) in Q2 2018, closing a stake of 347,250 shares — an estimated $19.3M sold.
Boston Trust Walden first reported a position in MD in Q2 2013 and held it in 20 quarters. The position peaked at $19.3M in Q1 2018. 322 funds tracked by Wall St. Rank hold MD as of Q2 2018.
- Boston Trust Walden reported no remaining Pediatrix Medical position as of Q2 2018 after selling out during the quarter.
- Boston Trust Walden sold 347,250 Pediatrix Medical shares in Q2 2018, an estimated $19.3M.
- Boston Trust Walden first reported a position in Pediatrix Medical in Q2 2013 and held it in 20 quarters.
- Boston Trust Walden's Pediatrix Medical position peaked at $19.3M in Q1 2018.
- 322 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2018.
Based on Boston Trust Walden's 13F filing for Q2 2018, filed 25 Jul 2018.